1.
Bioorg Med Chem Lett
; 20(15): 4683-8, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-20566291
RESUMEN
Optimization of the novel alpha-2-delta-1 ligand 4 provided compounds 37 and 38 which have improved DMPK profiles, good in vivo analgesic activity and in vitro selectivity over alpha-2-delta-2. An in-house P-gp prediction programme and the MetaSite software package were used to help solve the specific problems of high P-gp efflux and high in vivo clearance.